about
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesHigh-sensitivity cardiac troponin testing in routine practice: economic and organizational advantagesCardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaDiagnostic algorithms for acute coronary syndrome-is one better than another?The clinics of acute coronary syndromeAcute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and managementDrug-eluting stents and acute myocardial infarction: A lethal combination or friends?Biomarkers of acute myocardial infarction in the elderly: troponin and beyondRedefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction?Microengineering in cardiovascular research: new developments and translational applications.Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyCardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysisSorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patientsPostoperative vascular complications in unrecognised Obstructive Sleep apnoea (POSA) study protocol: an observational cohort study in moderate-to-high risk patients undergoing non-cardiac surgeryPrerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking?Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarctionThe International Committee of Medical Journal Editors proposal for sharing clinical trial data and the possible implications for the peer review processAutomatically Detecting Acute Myocardial Infarction Events from EHR Text: A Preliminary StudyPrevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literatureImplications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectorisExpanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United StatesManagement of coronary artery disease and acute coronary syndrome in the chronic kidney disease population-A review of the current literature.Myocardial infarction with non obstructive coronary arteries (MINOCA): a whole new ball game.Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.Mechanistic Pathways of Sex Differences in Cardiovascular Disease.Initial electrocardiogram as determinant of hospital course in ST elevation myocardial infarction.Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study.Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.The association of angiographic collaterals with long-term clinical outcomes in patients with chronic stable angina.Effectiveness of the Chest Pain Choice decision aid in emergency department patients with low-risk chest pain: study protocol for a multicenter randomized trial.Novel attenuation correction of SPECT images using scatter photopeak window data for the detection of coronary artery disease.ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI studyClinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database.In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR.Elevated Troponin I in the Absence of Coronary Artery Disease: A Case Report With Review of Literature.Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review.
P2860
Q24202522-F6656261-91D1-4890-AB96-036C9FFF8971Q24202999-9FA32A09-4AF1-4B88-976C-65093BA9827BQ26738522-7DD51997-2672-4986-B8E2-C4D969C645A8Q26745756-4DE408AE-6D1F-4D44-9B97-8486532D4279Q26746722-CF16951D-26D2-4FB0-A4DB-EE2241BE5988Q26746739-D01210C4-7758-4348-81AF-2813D609C134Q26830836-2BAF030A-091A-46D6-A55F-D0099AA5412FQ26865052-1D70CD60-A9E8-4F42-91F1-FED728A09EAAQ27005967-49717CFD-135C-41AE-A142-2A77F21C2DE6Q27013677-AA515AD9-10A5-437D-9A4E-1F11DF02D051Q27015747-B34D94B2-C473-4AC5-9B4A-B84002D51D38Q27026525-042ADA76-D152-4336-8B86-BB371FE0C5C2Q27687888-F30A78F5-EDBC-4F84-A06F-5F38DFA0DCE4Q28076541-CF2E8A4D-BF6C-47AA-8B35-5D92945C0EF3Q28085167-37CBA6D8-2445-40A3-B6C0-E0F51BAECC0CQ28304115-8B0EEB98-F59F-4DE1-BE9A-292D1964EEAFQ28394914-E6F4F282-ED35-4554-BCD5-D8A7AED66650Q28397856-4B9EAE82-8388-414F-A219-35EF3A9E51D8Q28539426-BC54494D-1B9E-46F7-8F1B-5AA60CDA3991Q28600876-C44C91AF-B9DE-4C98-A96A-6F570107D06BQ28648036-5171DB4F-54B0-46A9-90ED-6654295A801FQ28659910-AC3F352E-D581-405B-A335-70CA50ABA92BQ28660419-FA2DE470-EA90-46BF-9F22-C568C240C469Q28682030-A0E4C922-045D-4A7D-8623-EA2A4377DC27Q30238977-78964560-511B-4C5E-9BD5-012303B61482Q30240564-B48C710D-15AC-4483-8B71-29AB158790D8Q30241704-112ADFAF-979C-40C6-AF99-DBE8932DF2CBQ30241924-9DB01E9C-C898-4665-BFCE-4D168EFF00FCQ30275113-CAA6B613-FAF2-42C2-B975-D77AB7A3C7AFQ30409147-3A1BCD3F-45A4-474E-A656-C24C8E3893BDQ30449589-D35ED1BC-2F15-44E7-98F0-DF140653F02CQ30457953-CF4EC9E0-B972-4DED-B44E-09D8BBE5E9F1Q30578685-B19AF374-9A86-4926-AEA8-7E46E97BAED4Q30688133-CA12D433-F40F-4DD5-89CE-471D4BD1A533Q30697207-A3C13987-7CE0-4213-B452-15095821F842Q30876324-38195A82-0C3B-4F59-A4E0-7C661EAA4705Q31034537-B2090253-EE1C-4942-AE1A-56CC2C2AEEC8Q31042856-4ACF059A-00EC-49F5-BD46-31CBCCDF7F44Q33166211-17D593D1-B5F6-4166-904D-F10DD4301C6CQ33166383-14B39294-70BD-478B-933C-F86219D632A9
P2860
description
im August 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 24 August 2012
@en
наукова стаття, опублікована в серпні 2012
@uk
name
Third Universal Definition of Myocardial Infarction
@en
type
label
Third Universal Definition of Myocardial Infarction
@en
prefLabel
Third Universal Definition of Myocardial Infarction
@en
P2093
P50
P1433
P1476
Third universal definition of myocardial infarction
@en
P2093
Alexander N Parkhomenko
Alfred A Bove
Allan S Jaffe
Barry F Uretsky
Bernard R Chaitman
Bertil Lindahl
David A Morrow
David Wood
P304
P356
10.1161/CIR.0B013E31826E1058
P407
P577
2012-08-24T00:00:00Z